The market for health screening is projected to increase rapidly. As per a study conducted by the University of Utah GSLC, telomere test kits in cellular health screening and many other applications have increased, which is expected to increase the health screening market in the forecast period. Therefore, an increase in the frequency of chronic diseases and an increase in the elderly population has resulted in the rising demand for health screening in the market.
According to Data Bridge Market Research the Global Health Screening Market is tend to be around 12.4% in the mentioned forecast period. The market was valued at USD 2,11,225.2 million in 2021 and is expected to reach USD 6,09,134 million by 2029.
“Increasing Demand of Home Diagnostic Tests Facilitate the Market Growth”
The use of home diagnostic tests is considerably rising worldwide. The increasing number of campaigns to educate people about the signs of chronic diseases and ways to prevent them to contain disease epidemics are anticipated to fuel growth. Thus, there is a major demand for health screening kits and services because of greater patient awareness. Additionally, the use of these devices helps to optimize prompt treatment decisions, increases the effectiveness of care given, and significantly lowers diagnosis costs, particularly in resource-constrained countries with inadequate laboratory facilities.
What restraints the growth of Global Health Screening Market?
“Cost and Unstable Nature of the Kits”
The increasing cost of the kits can be the factor that can limit the growth of health screening market. Not all the countries can afford the kits, especially the people belonging to the middle and lower economic groups. Furthermore, the instability of kits and fragility of samples making the results less sensitive and the procedure less efficient, can be the primary factors decreasing the growth of health screening market. Such instances are estimated to impact the market.
Segmentation: Global Health Screening Market
The health screening market is segmented on the basis of test type, package type, panel type, sample type, technology, condition, sample collection sites, and distribution channel
- Based on test type, the health screening market is segmented into cholesterol tests, diabetes test, cancer screening, general check up test, STDs, blood pressure test and others.
- Based on package type, the health screening market is segmented into basic health screening, senior citizen profile, women health check, men health check, heart check, diabetes check and others.
- Based on panel type, the health screening market is bifurcated into multi-test panels and single-test panels.
- Based on sample type, the health screening market is bifurcated into blood, urine, serum, saliva and others.
- Based on technology, the health screening market is bifurcated into immunoassays, medical imaging, qPCR (quantitative polymerase chain reaction), q-fish (quantitative fluorescence, in situ hybridization), TRF (terminal restriction fragment), stela (single telomere length analysis) and others.
- Based on condition, the health screening market is bifurcated into cardiovascular disease, metabolic disorders, cancer, inflammatory conditions, musculoskeletal disorders, neurological conditions, hepatitis-c complications, immunology-related conditions and others.
- Based on end user, the health screening market is bifurcated into hospitals, eye care clinic, lasik centers, others.
- Based on distribution channel, the health screening market is bifurcated into direct tenders, retail sales and others.
Regional Insights: North America is expected to dominate the Global Health Screening Market
North America dominates the market because of the wide presence of a well-established healthcare sector and development of advanced technology in this region. Moreover, increasing presence of major market players will increase the market’s growth rate in this region. Additionally, easy adoption of advanced technologies, and the higher burden of infectious and chronic diseases in the population are leading to regional growth.
Asia-Pacific is expected to grow in the forecast period of 2022-2029 because of the increasing prevalence of chronic diseases and the rising number of elderly populations in this region. The improved adoption of tests and health consciousness among adult individuals are the major driving factors in the Asia Pacific region. Furthermore, the improved research on telomere for senescence and government initiatives used for the prevention of diseases is leading to the regional growth.
To know more about the study visit, https://www.databridgemarketresearch.com/reports/global-health-screening-market
Recent Developments in Global Health Screening Market
- In 2021, Evoq Technologies LLC announced the launch of first smartphone-based product for retinal health testing. The "SmartERG" Platform is designed to evaluate the retinal health of the eye in novel ways. The SmartERG Platform will provide a breakthrough delivery approach for ophthalmic patient care with the simple patient-provider connection, cloud-based analytical services, and a great fit for artificial intelligence.
- In 2021, Eurofins Scientific SE’s subsidiary Transplant Genomics launched OmniGraf. It combines the Viracor TRAC donor-derived cell-free DNA assays with the TruGraf blood gene expression test. OmniGraf Kidney is the first diagnostic tool for renal transplant recipients that incorporates cell-free DNA and gene expression data. The test offers patients with the most accurate and timely assessment of kidney transplant rejection when paired with TGI's unique technology and machine learning.
The Prominent Key Players Operating in the Global Health Screening Market Include:
- Quest Diagnostics Incorporated (U.S.)
- GRAIL (U.S.)
- Eurofins Scientific (Luxembourg)
- Exact Sciences Corporation (U.S.)
- SYNLAB International GmbH (Germany)
- UNILABS (Switzerland)
- LabPLUS (U.S.)
- BioReference Laboratories (U.S.)
- Sonic Healthcare Limited (Australia)
- Cerba Healthcare (France)
- Quidel Corporation (U.S.)
- Innova Medical Group (U.S.)
- Amedes Holding GmbH (Germany)
- RadNet, Inc. (U.S.)
- Natera, Inc. (U.S.)
- Trinity Biotech (Ireland)
- Nuffield Health (U.K.)
- RepeatDx (Canada)
- NeoGenomics Laboratories (U.S.)
- H.U Group Holdings, Inc. (Japan)
- ARUP Laboratories (U.S.)
- Q2 Solutions (U.S.)
- Genova Diagnostics (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of global health screening market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Health Screening Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
